Description
Regenerative medicine is a critical medical field in extending and improving the quality of human life. However, many past and current regenerative medicine treatments such as the use of embryonic stem cells have been met with significant backlash due to ethical and legal concerns. Therefore, IPSCs have the capability of sidestepping these ethical concerns, but require a reformatting of FDA regulations and investment into research targeting the scaling of IPSCs in order for the treatment to reach its full potential.
Details
Title
- Assessing the Viability of IPSCs as a Solution to Stem Cell Concerns
Contributors
- Tran, Kyle (Author)
- Martin, Thomas (Thesis director)
- Becker, Matthew (Committee member)
- Barrett, The Honors College (Contributor)
- Harrington Bioengineering Program (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2024-05
Resource Type
Collections this item is in